To the Editor: Drs Pogach and Aron1 used the Toyota example of failure to quickly “pull the cord” at the first sign of a safety or quality problem to suggest leading guideline and measure development organizations did not respond to changing evidence on control of glycated hemoglobin (HbA1c) levels in patients with diabetes. In fact, the National Committee for Quality Assurance (NCQA) did respond quickly when the National Institutes of Health suspended the ACCORD (Action to Control Cardiovascular Risk in Diabetes) study2 intervention group in February 2008 and the ACCORD and ADVANCE3 (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) studies were published later that year.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.